Circulating MicroRNAs in Elderly Type 2 Diabetic Patients

被引:35
作者
Catanzaro, Giuseppina [1 ]
Besharat, Zein Mersini [1 ]
Chiacchiarini, Martina [2 ]
Abballe, Luana [1 ]
Sabato, Claudia [2 ]
Vacca, Alessandra [1 ]
Borgiani, Paola [3 ]
Dotta, Francesco [4 ]
Tesauro, Manfredi [5 ]
Po, Agnese [2 ]
Ferretti, Elisabetta [1 ]
机构
[1] Sapienza Univ Rome, Dept Expt Med, Rome, Italy
[2] Sapienza Univ Rome, Dept Mol Med, Rome, Italy
[3] Tor Vergata Univ, Dept Biomed & Prevent, Rome, Italy
[4] Fdn Umberto Mario ONLUS, Rome, Italy
[5] Tor Vergata Univ, Dept Syst Med, Hypertens & Nephrol Unit, Rome, Italy
关键词
TO-MESENCHYMAL TRANSITION; BIOMARKERS; PLASMA; IDENTIFICATION; NEPHROPATHY; MIR-378; MIR-126;
D O I
10.1155/2018/6872635
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The circulating microRNAs (miRNAs) associated with type 2 diabetes (T2D) in elderly patients are still being defined. To identify novel miRNA biomarker candidates for monitoring responses to sitagliptin in such patients, we prospectively studied 40 T2D patients (age > 65) with HbA1c levels of 7.5-9.0% on metformin. After collection of baseline blood samples (t(0)), the dipeptidyl peptidase-IV (DPP-IV) inhibitor (DPP-IVi) sitagliptin was added to the metformin regimen, and patients were followed for 15 months. Patients with HbA1c < 7.5% or HbA1c reduction > 0.5% after 3 and 15 months of therapy were classified as "responders" (group R, n = 34); all others were classified as "nonresponders" (group NR, n = 6). Circulating miRNA profiling was performed on plasma collected in each group before and after 15 months of therapy (t(0) and t(15)). Intra-and intergroup comparison of miRNA profiles pinpointed three miRNAs that correlated with responses to sitagliptin: miR-378, which is a candidate biomarker of resistance to this DPP-IVi, and miR-126-3p and miR-223, which are associated with positive responses to the drug. The translational implications are as immediate as evident, with the possibility to develop noninvasive diagnostic tools to predict drug response and development of chronic complications.
引用
收藏
页数:11
相关论文
共 41 条
[1]
Bansal VS, 2013, INDIAN J MED RES, V137, P695
[2]
miR-296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells [J].
Barbagallo, Davide ;
Piro, Salvatore ;
Condorelli, Angelo G. ;
Mascali, Loriana G. ;
Urbano, Francesca ;
Parrinello, Nunziatina ;
Monello, Adelina ;
Statello, Luisa ;
Ragusa, Marco ;
Rabuazzo, Agata M. ;
Di Pietro, Cinzia ;
Purrello, Francesco ;
Purrello, Michele .
BMC GENOMICS, 2013, 14
[3]
Circulating MicroRNAs Associate With Diabetic Nephropathy and Systemic Microvascular Damage and Normalize After Simultaneous Pancreas-Kidney Transplantation [J].
Bijkerk, R. ;
Duijs, J. M. G. J. ;
Khairoun, M. ;
ter Horst, C. J. H. ;
van der Pol, P. ;
Mallat, M. J. ;
Rotmans, J. I. ;
de Vries, A. P. J. ;
de Koning, E. J. ;
de Fijter, J. W. ;
Rabelink, T. J. ;
van Zonneveld, A. J. ;
Reinders, M. E. J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (04) :1081-1090
[4]
GLP-1-Based Therapy for Diabetes: What You Do Not Know Can Hurt You [J].
Butler, Peter C. ;
Dry, Sarah ;
Elashoff, Robert .
DIABETES CARE, 2010, 33 (02) :453-455
[5]
MicroRNAs-Proteomic Networks Characterizing Human Medulloblastoma-SLCs [J].
Catanzaro, Giuseppina ;
Besharat, Zein Mersini ;
Garg, Neha ;
Ronci, Maurizio ;
Pieroni, Luisa ;
Miele, Evelina ;
Mastronuzzi, Angela ;
Carai, Andrea ;
Alfano, Vincenzo ;
Po, Agnese ;
Screpanti, Isabella ;
Locatelli, Franco ;
Urbani, Andrea ;
Ferretti, Elisabetta .
STEM CELLS INTERNATIONAL, 2016, 2016
[6]
Cazarim MD, 2017, DIABETES METAB SYND, V11, pS859, DOI 10.1016/j.dsx.2017.07.006
[7]
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes [J].
Ciccacci, Cinzia ;
Morganti, Roberto ;
Di Fusco, Davide ;
D'Amato, Cinzia ;
Cacciotti, Laura ;
Greco, Carla ;
Rufini, Sara ;
Novelli, Giuseppe ;
Sangiuolo, Federica ;
Marfia, Girolama A. ;
Borgiani, Paola ;
Spallone, Vincenza .
ACTA DIABETOLOGICA, 2014, 51 (04) :663-671
[8]
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes [J].
de Graaf, Chris ;
Donnelly, Dan ;
Wootten, Denise ;
Lau, Jesper ;
Sexton, Patrick M. ;
Miller, Laurence J. ;
Ahn, Jung-Mo ;
Liao, Jiayu ;
Fletcher, Madeleine M. ;
Yang, Dehua ;
Brown, Alastair J. H. ;
Zhou, Caihong ;
Deng, Jiejie ;
Wang, Ming-Wei .
PHARMACOLOGICAL REVIEWS, 2016, 68 (04) :954-1013
[9]
MicroRNAs as biomarkers for CNS cancer and other disorders [J].
De Smaele, Enrico ;
Ferretti, Elisabetta ;
Gulino, Alberto .
BRAIN RESEARCH, 2010, 1338 :100-111
[10]
MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics [J].
Deiuliis, J. A. .
INTERNATIONAL JOURNAL OF OBESITY, 2016, 40 (01) :88-101